The people living with hiv antiretroviral therapy coverage in Belize currently stands at 44%, marking a decrease of 2% (-4.3%) compared to 2021.
People living with HIV antiretroviral therapy coverage in Belize
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Belize
Antiretroviral therapy coverage
More indicators for Belize
Male unintentional poisoning
0.5
0.0
(2019)
Female wasting in children
1.4%
-2%
(2015)
Female prevalence of HIV
0.5%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar109
+intl dollar17
(2021)
Birth registration
95.7%
+0.5%
(2015)
Contraceptive modern method prevalence
48.5%
-3.5%
(2016)
Belize Antiretroviral therapy coverage between 2000 and 2022
Period | Antiretroviral therapy coverage | Change |
---|---|---|
2022 | 44% | -2% |
2021 | 46% | +2% |
2020 | 44% | 0% |
2019 | 44% | +1% |
2018 | 43% | +3% |
2017 | 40% | 0% |
2016 | 40% | +2% |
2015 | 38% | +2% |
2014 | 36% | +2% |
2013 | 34% | +3% |
2012 | 31% | +1% |
2011 | 30% | +3% |
2010 | 27% | +3% |
2009 | 24% | +6% |
2008 | 18% | +3% |
2007 | 15% | +1% |
2006 | 14% | +3% |
2005 | 11% | +4% |
2004 | 7% | -1% |
2003 | 8% | +5% |
2002 | 3% | +2% |
2001 | 1% | 0% |
2000 | 1% |